WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported third-quarter net income of $33.5 million.

The Waltham, Massachusetts-based company said it had net income of 58 cents per share. Earnings, adjusted for non-recurring costs, came to 78 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 64 cents per share.

The drug developer posted revenue of $178.2 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $164.7 million.

Repligen expects full-year earnings in the range of $2.86 to $2.91 per share, with revenue in the range of $655 million to $665 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGEN at https://www.zacks.com/ap/RGEN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News